Free Trial
→ July 2025 Rule Change to Impact Retirement Investors (From Premier Gold Co) (Ad) Buy GKOS Stock  Free GKOS Stock Alerts

Glaukos (GKOS) Financials

Glaukos logo
$95.12 -1.85 (-1.91%)
Closing price 05/28/2025 03:59 PM Eastern
Extended Trading
$100.46 +5.33 (+5.61%)
As of 08:41 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Glaukos

Annual Income Statements for Glaukos

This table shows Glaukos' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders		 -146 -135 -99 -50 -120 15 -13 -0.09 4.52 -37
Consolidated Net Income / (Loss)		 -146 -135 -99 -50 -120 15 -13 -0.09 4.52 -38
Net Income / (Loss) Continuing Operations		 -146 -135 -99 -50 -120 15 -13 -0.09 4.52 -38
Total Pre-Tax Income 		-146 -134 -98 -49 -132 -50 -12 0.00 4.57 -38
Total Operating Income		 -122 -129 -82 -33 -124 -50 -13 -2.28 4.24 -10
Total Gross Profit		 289 239 214 227 133 198 156 138 98 59
Total Revenue		 383 315 283 294 225 237 181 159 114 72
Operating Revenue		 383 315 283 294 225 237 181 159 114 72
Total Cost of Revenue		 94 76 69 67 92 39 25 21 16 13
Operating Cost of Revenue		 94 76 69 67 92 39 25 21 16 13
Total Operating Expenses		 412 368 296 260 257 249 169 140 94 69
Selling, General & Admin Expense		 261 224 193 179 171 177 - 96 65 44
Research & Development Expense		 151 144 133 111 85 72 50 44 29 25
Other Special Charges / (Income)		 0.00 0.00 -30 -30 - 0.00 - - - -
Total Other Income / (Expense), net		 -23 -5.03 -16 -16 -8.76 0.51 0.63 2.28 0.32 -28
Interest Expense		 34 14 18 18 11 2.91 1.62 -0.91 - 1.26
Interest & Investment Income		 11 9.16 2.38 1.29 2.38 3.17 2.25 1.38 0.89 -26
Income Tax Expense		 0.77 0.93 0.77 0.33 -12 -65 0.58 0.09 0.04 0.03
Basic Earnings per Share		 ($2.77) ($2.78) ($2.09) ($1.07) ($2.70) $0.41 ($0.37) $0.00 $0.14 ($2.13)
Weighted Average Basic Shares Outstanding		 52.76M 48.43M 47.44M 46.42M 44.50M 37.36M 35.32M 34.38M 32.93M 17.47M
Diluted Earnings per Share		 ($2.77) ($2.78) ($2.09) ($1.07) ($2.70) $0.37 ($0.37) $0.00 $0.12 ($2.13)
Weighted Average Diluted Shares Outstanding		 52.76M 48.43M 47.44M 46.42M 44.50M 41.15M 35.32M 34.38M 36.46M 17.47M
Weighted Average Basic & Diluted Shares Outstanding		 56.57M 49.47M 47.88M 47.05M 45.79M 43.74M 35M 34.74M 32.30M 17.50M

Quarterly Income Statements for Glaukos

This table shows Glaukos' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 -18 -34 -21 -51 -41 -37 -30 -33 -35 -31 -28
Consolidated Net Income / (Loss)		 -18 -34 -21 -51 -41 -37 -30 -33 -35 -31 -28
Net Income / (Loss) Continuing Operations		 -18 -34 -21 -51 -41 -37 -30 -33 -35 -31 -28
Total Pre-Tax Income 		-18 -34 -21 -50 -40 -37 -30 -32 -34 -31 -27
Total Operating Income		 -21 -29 -25 -30 -39 -39 -28 -29 -33 -34 -22
Total Gross Profit		 82 77 74 73 65 63 60 60 56 54 54
Total Revenue		 107 105 97 96 86 82 78 80 74 71 71
Operating Revenue		 107 105 97 96 86 82 78 80 74 71 71
Total Cost of Revenue		 24 29 23 23 20 19 19 20 18 17 17
Operating Cost of Revenue		 24 29 23 23 20 19 19 20 18 17 17
Total Operating Expenses		 103 106 99 103 104 102 88 89 89 88 76
Selling, General & Admin Expense		 71 69 64 66 62 63 54 53 54 52 47
Research & Development Expense		 32 37 35 37 42 39 33 36 35 36 29
Total Other Income / (Expense), net		 2.86 -5.03 3.43 -20 -1.40 1.90 -2.40 -3.30 -1.23 2.57 -5.72
Interest Expense		 1.16 7.86 1.66 21 3.45 3.99 3.40 3.40 3.41 8.18 3.48
Interest & Investment Income		 3.08 2.49 2.70 2.83 3.08 2.38 2.71 1.89 2.18 3.94 -2.24
Other Income / (Expense), net		 0.95 - 2.39 -1.70 -1.03 - -1.71 -1.80 - - -
Income Tax Expense		 0.33 -0.11 0.18 0.33 0.38 0.06 0.04 0.44 0.40 0.30 0.25
Basic Earnings per Share		 ($0.32) ($0.56) ($0.39) ($1.00) ($0.82) ($0.75) ($0.63) ($0.68) ($0.72) ($0.66) ($0.58)
Weighted Average Basic Shares Outstanding		 56.64M 52.76M 55.04M 50.72M 49.58M 48.43M 48.68M 48.28M 47.88M 47.44M 47.61M
Diluted Earnings per Share		 ($0.32) ($0.56) ($0.39) ($1.00) ($0.82) ($0.75) ($0.63) ($0.68) ($0.72) ($0.66) ($0.58)
Weighted Average Diluted Shares Outstanding		 56.64M 52.76M 55.04M 50.72M 49.58M 48.43M 48.68M 48.28M 47.88M 47.44M 47.61M
Weighted Average Basic & Diluted Shares Outstanding		 57.14M 56.57M 55.14M 54.95M 50.37M 49.47M 48.80M 48.65M 48.21M 47.88M 47.70M

Annual Cash Flow Statements for Glaukos

This table details how cash moves in and out of Glaukos' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents		 75 -27 16 3.96 34 33 14 18 -15 19
Net Cash From Operating Activities		 -61 -58 -33 25 -23 -0.37 19 26 12 -2.19
Net Cash From Continuing Operating Activities		 -61 -58 -33 25 -23 -0.37 19 26 12 -2.19
Net Income / (Loss) Continuing Operations		 -146 -135 -99 -50 -120 15 -13 -0.09 4.52 -38
Consolidated Net Income / (Loss)		 -146 -135 -99 -50 -120 15 -13 -0.09 4.52 -38
Depreciation Expense		 11 8.74 6.66 4.75 4.47 6.31 6.26 5.48 4.72 4.27
Amortization Expense		 30 25 31 32 61 3.22 -0.30 0.02 0.21 0.07
Non-Cash Adjustments To Reconcile Net Income		 84 54 42 35 47 49 28 17 9.15 35
Changes in Operating Assets and Liabilities, net		 -40 -10 -14 2.55 -15 -75 -1.66 4.03 -6.30 -3.38
Net Cash From Investing Activities		 48 14 45 -58 -205 43 -26 -12 -26 -86
Net Cash From Continuing Investing Activities		 48 14 45 -58 -205 43 -26 -12 -26 -86
Purchase of Property, Plant & Equipment		 -6.30 -20 -30 -48 -6.94 -4.72 -10 -6.31 -6.28 -0.88
Purchase of Investments		 -190 -266 -59 -215 -301 -80 -94 -94 -75 -70
Sale of Property, Plant & Equipment		 0.04 0.00 0.15 0.00 0.00 0.00 - - - -
Sale and/or Maturity of Investments		 247 303 135 207 105 80 79 89 55 -
Other Investing Activities, net		 -3.15 -3.17 -1.01 -2.08 -1.82 -1.61 -1.24 -0.66 - -15
Net Cash From Financing Activities		 92 15 6.25 39 263 -9.65 22 4.67 -1.64 107
Net Cash From Continuing Financing Activities		 92 15 6.25 39 263 -9.65 22 4.67 -1.64 107
Repayment of Debt		 -0.71 0.00 0.00 0.00 -9.61 -22 0.00 - -9.70 -18
Issuance of Debt		 53 0.00 0.00 - 288 0.00 0.00 - - 8.60
Issuance of Common Equity		 7.42 6.28 5.63 4.82 4.03 3.39 3.51 0.97 1.95 115
Other Financing Activities, net		 32 8.76 0.62 34 -19 9.46 18 3.70 6.11 2.16
Effect of Exchange Rate Changes		 -3.02 1.34 -1.47 -1.77 -0.09 -0.25 0.05 -0.43 0.37 -0.03
Cash Interest Paid		 9.21 12 12 12 5.38 0.00 0.00 - 0.29 0.83
Cash Income Taxes Paid		 1.36 1.56 0.52 0.27 0.48 0.17 0.40 0.01 0.51 0.03

Quarterly Cash Flow Statements for Glaukos

This table details how cash moves in and out of Glaukos' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 -55 69 32 24 -51 -15 14 17 -43 14 1.42
Net Cash From Operating Activities		 -19 0.51 -9.59 -18 -34 -11 -8.17 -8.16 -31 -4.14 -27
Net Cash From Continuing Operating Activities		 -19 0.51 -9.59 -18 -34 -11 -8.17 -8.16 -31 -4.14 -27
Net Income / (Loss) Continuing Operations		 -18 -34 -21 -51 -41 -37 -30 -33 -35 -31 -28
Consolidated Net Income / (Loss)		 -18 -34 -21 -51 -41 -37 -30 -33 -35 -31 -28
Depreciation Expense		 2.65 2.77 2.74 2.75 2.69 2.29 2.23 2.15 2.08 1.95 1.67
Amortization Expense		 5.51 13 5.36 5.38 5.46 5.93 5.87 6.29 6.52 10 6.73
Non-Cash Adjustments To Reconcile Net Income		 15 16 14 32 21 13 13 16 12 7.80 13
Changes in Operating Assets and Liabilities, net		 -23 1.68 -11 -8.23 -22 4.95 1.00 0.25 -16 7.23 -20
Net Cash From Investing Activities		 -37 12 31 35 -29 -13 15 26 -14 17 24
Net Cash From Continuing Investing Activities		 -37 12 31 35 -29 -13 15 26 -14 17 24
Purchase of Property, Plant & Equipment		 -1.94 -1.73 -1.45 -2.15 -0.97 -4.21 -3.36 -5.77 -6.91 -8.22 -6.04
Purchase of Investments		 -75 -67 -32 -42 -49 -72 -23 -74 -96 -12 -10
Sale and/or Maturity of Investments		 41 80 65 80 22 64 42 107 90 38 41
Other Investing Activities, net		 -1.15 0.08 -1.15 -1.04 -1.05 -1.02 -0.10 -1.52 -0.53 -0.84 0.00
Net Cash From Financing Activities		 1.95 60 9.67 8.59 13 7.30 7.47 -0.88 1.15 0.53 4.21
Net Cash From Continuing Financing Activities		 1.95 60 9.67 8.59 13 7.30 7.47 -0.88 1.15 0.53 4.21
Issuance of Common Equity		 2.96 - 4.73 - 2.69 - 4.12 - 2.16 - 3.85
Other Financing Activities, net		 -1.01 7.60 4.94 8.59 10 7.30 3.35 -0.88 -1.01 0.53 0.36
Other Net Changes in Cash		 -1.86 - - - - - - - - - -
Cash Interest Paid		 1.06 1.86 1.08 5.20 1.07 5.06 1.08 5.03 1.09 5.04 1.16
Cash Income Taxes Paid		 0.28 0.20 0.36 0.45 0.35 0.34 0.44 0.53 0.26 0.15 0.13

Annual Balance Sheets for Glaukos

This table presents Glaukos' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets		 975 940 1,002 1,050 1,006 818 207 166 134 117
Total Current Assets		 450 395 444 486 469 263 177 149 120 104
Cash & Equivalents		 170 93 120 101 97 62 30 25 6.49 22
Short-Term Investments		 149 202 233 313 308 112 111 95 89 70
Accounts Receivable		 61 40 36 33 36 38 19 17 14 7.55
Inventories, net		 58 42 38 23 16 43 13 11 6.84 4.10
Prepaid Expenses		 12 18 17 16 13 7.90 4.12 2.57 3.03 1.29
Plant, Property, & Equipment, net		 98 103 94 69 24 22 19 12 7.59 2.15
Total Noncurrent Assets		 427 442 464 495 512 533 11 4.58 6.76 10
Noncurrent Note & Lease Receivables		 42 44 47 49 51 54 - - - -
Goodwill		 66 66 66 66 66 66 - - - -
Intangible Assets		 263 283 308 333 358 383 - 3.15 6.57 10
Other Noncurrent Operating Assets		 51 43 36 37 27 21 2.26 1.20 0.19 0.15
Other Noncurrent Nonoperating Assets		 4.73 5.86 7.08 9.42 9.57 9.33 8.78 - - -
Total Liabilities & Shareholders' Equity		 975 940 1,002 1,050 1,006 818 207 166 134 117
Total Liabilities		 208 479 472 463 338 145 33 28 17 21
Total Current Liabilities		 75 74 72 63 50 58 30 27 17 20
Accounts Payable		 13 13 14 7.33 4.37 5.78 6.29 6.24 2.97 3.63
Accrued Expenses		 62 61 58 56 45 52 24 20 14 7.79
Total Noncurrent Liabilities		 133 405 400 399 288 87 2.75 0.85 0.16 1.11
Long-Term Debt		 0.00 283 281 280 189 0.00 - - - 0.77
Noncurrent Deferred & Payable Income Tax Liabilities		 6.93 7.14 7.26 7.32 11 9.63 - - - -
Other Noncurrent Operating Liabilities		 126 115 111 112 88 78 2.75 0.85 0.16 0.34
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 767 462 530 587 667 673 174 138 117 95
Total Preferred & Common Equity		 767 462 530 587 667 673 174 138 117 95
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 767 462 530 587 667 673 174 138 117 95
Common Stock		 1,510 1,060 998 952 977 862 378 331 309 292
Retained Earnings		 -745 -599 -464 -365 -310 -190 -205 -192 -192 -197
Treasury Stock		 -0.13 -0.13 -0.13 - -0.13 -0.13 -0.13 -0.13 -0.13 -0.13
Accumulated Other Comprehensive Income / (Loss)		 2.62 1.17 -2.98 0.02 1.00 1.33 0.74 -0.59 0.65 0.05

Quarterly Balance Sheets for Glaukos

This table presents Glaukos' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 966 927 920 933 949 957 973 1,008
Total Current Assets		 445 397 384 389 400 401 416 449
Cash & Equivalents		 114 100 68 42 109 95 76 104
Short-Term Investments		 184 162 194 230 192 209 241 258
Accounts Receivable		 72 56 51 47 39 39 38 35
Inventories, net		 59 60 56 50 40 39 40 34
Prepaid Expenses		 15 19 14 19 20 19 20 18
Plant, Property, & Equipment, net		 97 99 100 102 103 103 98 87
Total Noncurrent Assets		 425 431 436 443 446 453 458 463
Noncurrent Note & Lease Receivables		 41 42 43 44 45 45 46 47
Goodwill		 66 66 66 66 66 66 66 66
Intangible Assets		 258 269 276 282 289 295 302 314
Other Noncurrent Operating Assets		 55 48 46 45 40 40 38 26
Other Noncurrent Nonoperating Assets		 4.73 4.73 4.73 5.86 5.86 5.86 7.08 9.08
Total Liabilities & Shareholders' Equity		 966 927 920 933 949 957 973 1,008
Total Liabilities		 202 258 255 483 471 468 464 460
Total Current Liabilities		 69 72 70 72 67 64 62 61
Accounts Payable		 16 11 12 13 10 8.56 12 11
Accrued Expenses		 53 61 59 59 57 55 50 49
Total Noncurrent Liabilities		 134 186 184 410 404 404 402 399
Noncurrent Deferred & Payable Income Tax Liabilities		 6.92 7.14 7.14 7.14 7.25 7.26 7.26 7.30
Other Noncurrent Operating Liabilities		 127 122 121 120 114 115 113 111
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 764 669 665 451 478 489 509 549
Total Preferred & Common Equity		 764 669 665 451 478 489 509 549
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 764 669 665 451 478 489 509 549
Common Stock		 1,525 1,378 1,354 1,089 1,039 1,021 1,009 985
Retained Earnings		 -764 -712 -690 -640 -562 -532 -499 -433
Treasury Stock		 -0.13 -0.13 -0.13 -0.13 -0.13 -0.13 -0.13 -0.13
Accumulated Other Comprehensive Income / (Loss)		 2.61 2.62 2.19 1.44 0.76 -0.39 -1.33 -3.82

Annual Metrics And Ratios for Glaukos

This table displays calculated financial ratios and metrics derived from Glaukos' official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 21.85% 11.26% -3.79% 30.70% -5.07% 30.73% 13.83% 39.21% 59.55% 57.28%
EBITDA Growth		 14.30% -111.93% -1,239.09% 106.83% -42.68% -476.01% -318.35% -62.58% 221.32% 20.59%
EBIT Growth		 4.92% -56.35% -150.40% 73.39% -146.93% -284.83% -470.01% -162.05% 132.17% 13.20%
NOPAT Growth		 4.92% -56.35% -150.40% 73.39% -145.67% -286.80% -104.34% 4,895.23% 158.29% 21.83%
Net Income Growth		 -8.70% -35.75% -100.02% 58.79% -880.26% 219.10% -13,977.17% -102.03% 111.80% -172.61%
EPS Growth		 0.36% -33.01% -95.33% 60.37% -829.73% 200.00% 0.00% -100.00% 105.63% 59.74%
Operating Cash Flow Growth		 -6.16% -74.59% -233.90% 207.48% -6,129.81% -101.96% -27.70% 111.97% 662.57% 69.21%
Free Cash Flow Firm Growth		 -4.87% -24.67% -175.51% 39.71% 92.12% -3,349.74% -106.84% 6,077.99% 52.24% 67.24%
Invested Capital Growth		 0.01% -1.86% 1.79% 0.18% -9.60% 1,891.96% 28.19% -10.47% 56.63% 1.65%
Revenue Q/Q Growth		 6.42% 3.67% -0.71% 0.00% 3.39% 5.23% 7.36% 5.62% 12.71% 0.00%
EBITDA Q/Q Growth		 14.33% -11.32% -40.25% -89.48% 46.40% -216.34% 12.12% 8.56% 32.37% 0.00%
EBIT Q/Q Growth		 7.52% -3.95% -23.88% -24.54% 12.90% -167.60% 9.50% 2.73% 107.92% 0.00%
NOPAT Q/Q Growth		 7.52% -3.95% -23.88% -24.54% 12.90% -168.97% 9.50% 12,884.16% 137.62% 0.00%
Net Income Q/Q Growth		 2.14% -4.11% -10.70% -29.25% -64.59% 179.60% 5.63% 90.46% 115.54% 0.00%
EPS Q/Q Growth		 6.42% -3.35% -10.58% -30.49% -75.32% 169.81% 2.63% 100.00% -98.73% 0.00%
Operating Cash Flow Q/Q Growth		 15.41% -12.74% 1.53% -38.17% 39.16% -101.76% 32.86% 54.32% 76.73% -43.57%
Free Cash Flow Firm Q/Q Growth		 11.95% 10.10% -22.92% -129.86% 92.43% -3,062.04% -17.57% 4,048.54% 0.00% 0.00%
Invested Capital Q/Q Growth		 -3.23% -2.23% 0.55% 0.31% -1.68% 1,630.34% -3.82% -17.61% 9.58% 0.00%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 75.48% 75.99% 75.61% 77.34% 59.23% 83.72% 86.17% 86.78% 85.86% 81.89%
EBITDA Margin		 -21.31% -30.30% -15.91% 1.34% -25.69% -17.09% -3.88% 2.02% 7.52% -9.90%
Operating Margin		 -31.91% -40.89% -29.10% -11.18% -54.92% -21.22% -7.17% -1.43% 3.71% -14.36%
EBIT Margin		 -31.91% -40.89% -29.10% -11.18% -54.92% -21.11% -7.17% -1.43% 3.21% -15.94%
Profit (Net Income) Margin		 -38.17% -42.79% -35.07% -16.87% -53.50% 6.51% -7.14% -0.06% 3.95% -53.45%
Tax Burden Percent		 100.53% 100.70% 100.78% 100.66% 90.96% -30.83% 104.71% -9,200.00% 99.06% 100.09%
Interest Burden Percent		 118.99% 103.91% 119.58% 149.88% 107.09% 100.00% 95.12% -0.04% 124.18% 335.04%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 9,300.00% 0.94% 0.00%
Return on Invested Capital (ROIC)		 -19.32% -20.13% -12.87% -5.19% -18.54% -13.68% -41.57% 1,033.24% 23.93% -53.10%
ROIC Less NNEP Spread (ROIC-NNEP)		 16.17% 71.87% 24.62% 9.26% -1.94% -44.13% -38.70% 1,228.67% 23.57% 43.34%
Return on Net Nonoperating Assets (RNNOA)		 -4.50% -7.02% -4.89% -2.72% 0.59% 17.32% 33.27% -1,033.32% -19.67% -30.51%
Return on Equity (ROE)		 -23.83% -27.16% -17.76% -7.91% -17.95% 3.64% -8.30% -0.07% 4.26% -83.61%
Cash Return on Invested Capital (CROIC)		 -19.33% -18.26% -14.64% -5.37% -8.46% -194.56% -66.28% 1,044.29% -20.21% -54.74%
Operating Return on Assets (OROA)		 -12.78% -13.25% -8.02% -3.20% -13.55% -9.76% -6.98% -1.52% 2.93% -16.02%
Return on Assets (ROA)		 -15.29% -13.86% -9.67% -4.83% -13.20% 3.01% -6.95% -0.06% 3.60% -53.72%
Return on Common Equity (ROCE)		 -23.83% -27.16% -17.76% -7.91% -17.95% 3.64% -8.30% -0.07% 4.26% 51.18%
Return on Equity Simple (ROE_SIMPLE)		 -19.09% -29.16% -18.72% -8.45% -18.03% 2.29% -7.45% -0.07% 3.86% -40.26%
Net Operating Profit after Tax (NOPAT)		 -86 -90 -58 -23 -86 -35 -9.10 210 4.20 -7.21
NOPAT Margin		 -22.34% -28.63% -20.37% -7.83% -38.45% -14.86% -5.02% 131.77% 3.67% -10.05%
Net Nonoperating Expense Percent (NNEP)		 -35.49% -92.01% -37.49% -14.45% -16.61% 30.45% -2.87% -195.43% 0.36% -96.44%
Return On Investment Capital (ROIC_SIMPLE)		 -11.17% -12.10% -7.10% - - - - - - -
Cost of Revenue to Revenue		 24.52% 24.01% 24.39% 22.66% 40.77% 16.28% 13.83% 13.22% 14.14% 18.11%
SG&A Expenses to Revenue		 68.10% 71.20% 68.20% 60.97% 76.19% 74.53% 0.00% 60.44% 56.61% 61.31%
R&D to Revenue		 39.29% 45.68% 47.12% 37.75% 37.96% 30.40% 27.40% 27.77% 25.55% 34.93%
Operating Expenses to Revenue		 107.39% 116.88% 104.71% 88.52% 114.15% 104.94% 93.34% 88.21% 82.15% 96.25%
Earnings before Interest and Taxes (EBIT)		 -122 -129 -82 -33 -124 -50 -13 -2.28 3.68 -11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -82 -95 -45 3.95 -58 -41 -7.03 3.22 8.61 -7.10
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 10.78 8.40 3.93 3.55 5.07 2.99 11.64 6.42 9.81 8.33
Price to Tangible Book Value (P/TBV)		 18.90 34.43 13.36 11.07 13.89 8.96 11.64 6.56 10.39 9.33
Price to Revenue (P/Rev)		 21.56 12.33 7.37 7.09 15.04 8.49 11.16 5.57 10.06 11.05
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 130.41 0.00 0.00 254.48 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.77% 0.00% 0.00% 0.39% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 17.93 8.72 4.46 4.39 7.15 3.75 76.56 40.00 49.22 51.97
Enterprise Value to Revenue (EV/Rev)		 20.73 12.29 7.11 6.63 14.09 7.75 10.39 4.82 9.22 9.92
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 493.61 0.00 0.00 0.00 238.31 122.55 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 286.97 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.66 251.10 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 78.91 0.00 0.00 99.83 29.42 85.70 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.62 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.61 0.53 0.48 0.28 0.00 0.00 0.00 0.00 0.10
Long-Term Debt to Equity		 0.00 0.61 0.53 0.48 0.28 0.00 0.00 0.00 0.00 0.01
Financial Leverage		 -0.28 -0.10 -0.20 -0.29 -0.30 -0.39 -0.86 -0.84 -0.83 -0.70
Leverage Ratio		 1.56 1.96 1.84 1.64 1.36 1.21 1.19 1.18 1.18 1.56
Compound Leverage Factor		 1.85 2.04 2.20 2.46 1.46 1.21 1.14 0.00 1.47 5.22
Debt to Total Capital		 0.00% 37.98% 34.68% 32.29% 22.11% 0.00% 0.00% 0.00% 0.00% 9.24%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 8.51%
Long-Term Debt to Total Capital		 0.00% 37.98% 34.68% 32.29% 22.11% 0.00% 0.00% 0.00% 0.00% 0.73%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 62.02% 65.32% 67.71% 77.89% 100.00% 100.00% 100.00% 100.00% 90.76%
Debt to EBITDA		 0.00 -2.97 -6.25 70.89 -3.28 0.00 0.00 0.00 0.00 -1.37
Net Debt to EBITDA		 0.00 0.13 1.58 -33.93 3.72 0.00 0.00 0.00 0.00 11.49
Long-Term Debt to EBITDA		 0.00 -2.97 -6.25 70.89 -3.28 0.00 0.00 0.00 0.00 -0.11
Debt to NOPAT		 0.00 -3.14 -4.88 -12.17 -2.19 0.00 0.00 0.00 0.00 -1.35
Net Debt to NOPAT		 0.00 0.14 1.24 5.82 2.49 0.00 0.00 0.00 0.00 11.31
Long-Term Debt to NOPAT		 0.00 -3.14 -4.88 -12.17 -2.19 0.00 0.00 0.00 0.00 -0.11
Altman Z-Score		 23.24 4.26 2.45 2.88 5.89 8.38 36.80 19.43 40.24 20.94
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 161.21%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 5.99 5.34 6.13 7.67 9.45 4.56 5.81 5.58 7.09 5.11
Quick Ratio		 5.05 4.53 5.37 7.06 8.86 3.68 5.24 5.06 6.50 4.85
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -86 -82 -66 -24 -39 -501 -15 212 -3.55 -7.43
Operating Cash Flow to CapEx		 -979.21% -285.25% -109.86% 51.71% -331.48% -7.81% 182.88% 413.42% 196.07% -249.49%
Free Cash Flow to Firm to Interest Expense		 -2.50 -5.76 -3.54 -1.35 -3.54 -171.84 -8.97 0.00 0.00 -5.91
Operating Cash Flow to Interest Expense		 -1.79 -4.07 -1.79 1.40 -2.06 -0.13 11.66 0.00 0.00 -1.74
Operating Cash Flow Less CapEx to Interest Expense		 -1.97 -5.50 -3.42 -1.30 -2.69 -1.75 5.28 0.00 0.00 -2.44
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.40 0.32 0.28 0.29 0.25 0.46 0.97 1.06 0.91 1.01
Accounts Receivable Turnover		 7.62 8.29 8.14 8.46 6.04 8.30 10.26 10.29 10.47 11.08
Inventory Turnover		 1.89 1.89 2.27 3.43 3.14 1.38 2.05 2.33 2.96 4.09
Fixed Asset Turnover		 3.81 3.19 3.46 6.32 9.77 11.50 11.72 16.43 23.47 34.94
Accounts Payable Turnover		 7.11 5.43 6.35 11.39 18.07 6.40 4.00 4.57 4.91 3.75
Days Sales Outstanding (DSO)		 47.87 44.03 44.85 43.14 60.42 43.96 35.57 35.48 34.86 32.95
Days Inventory Outstanding (DIO)		 193.44 192.77 161.00 106.33 116.18 264.19 178.34 156.63 123.43 89.30
Days Payable Outstanding (DPO)		 51.37 67.24 57.51 32.06 20.20 57.07 91.20 79.86 74.38 97.29
Cash Conversion Cycle (CCC)		 189.95 169.56 148.34 117.41 156.40 251.08 122.72 112.25 83.92 24.96
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 443 443 452 444 443 490 25 19 21 14
Invested Capital Turnover		 0.87 0.70 0.63 0.66 0.48 0.92 8.28 7.84 6.52 5.28
Increase / (Decrease) in Invested Capital		 0.03 -8.38 7.92 0.78 -47 465 5.41 -2.24 7.75 0.22
Enterprise Value (EV)		 7,948 3,866 2,012 1,950 3,169 1,837 1,883 768 1,055 711
Market Capitalization		 8,267 3,879 2,084 2,084 3,384 2,011 2,024 887 1,151 793
Book Value per Share		 $13.91 $9.46 $11.11 $12.52 $14.84 $18.23 $4.83 $4.00 $3.50 $2.97
Tangible Book Value per Share		 $7.93 $2.31 $3.27 $4.01 $5.42 $6.08 $4.83 $3.91 $3.30 $2.65
Total Capital		 767 745 811 867 857 673 174 138 117 105
Total Debt		 0.00 283 281 280 189 0.00 0.00 0.00 0.00 9.70
Total Long-Term Debt		 0.00 283 281 280 189 0.00 0.00 0.00 0.00 0.77
Net Debt		 -319 -13 -71 -134 -215 -174 -140 -119 -96 -82
Capital Expenditures (CapEx)		 6.26 20 30 48 6.94 4.72 10 6.31 6.28 0.88
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 56 26 19 8.72 15 31 5.71 3.66 7.24 1.51
Debt-free Net Working Capital (DFNWC)		 375 321 372 423 420 205 146 123 103 93
Net Working Capital (NWC)		 375 321 372 423 420 205 146 123 103 84
Net Nonoperating Expense (NNE)		 61 45 42 27 34 -51 3.85 210 -0.32 31
Net Nonoperating Obligations (NNO)		 -324 -19 -78 -143 -225 -183 -149 -119 -96 -82
Total Depreciation and Amortization (D&A)		 41 33 37 37 66 9.53 5.97 5.50 4.93 4.33
Debt-free, Cash-free Net Working Capital to Revenue		 14.54% 8.27% 6.65% 2.96% 6.83% 13.16% 3.15% 2.30% 6.33% 2.10%
Debt-free Net Working Capital to Revenue		 97.70% 102.14% 131.34% 143.79% 186.59% 86.58% 80.65% 77.03% 90.11% 129.30%
Net Working Capital to Revenue		 97.70% 102.14% 131.34% 143.79% 186.59% 86.58% 80.65% 77.03% 90.11% 116.85%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($2.77) ($2.78) $0.00 $0.00 ($2.70) $0.41 ($0.37) $0.00 $0.14 ($2.13)
Adjusted Weighted Average Basic Shares Outstanding		 52.76M 48.43M 0.00 0.00 44.50M 37.36M 35.32M 34.38M 32.93M 32.34M
Adjusted Diluted Earnings per Share		 ($2.77) ($2.78) $0.00 $0.00 ($2.70) $0.37 ($0.37) $0.00 $0.12 ($2.13)
Adjusted Weighted Average Diluted Shares Outstanding		 52.76M 48.43M 0.00 0.00 44.50M 41.15M 35.32M 34.38M 36.46M 32.34M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 ($2.13)
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 56.57M 49.47M 0.00 0.00 45.79M 43.74M 36.16M 34.74M 34.23M 17.47M
Normalized Net Operating Profit after Tax (NOPAT)		 -86 -90 -79 -44 -86 -35 -9.10 -1.60 4.20 -7.21
Normalized NOPAT Margin		 -22.34% -28.63% -27.79% -14.97% -38.45% -14.86% -5.02% -1.00% 3.67% -10.05%
Pre Tax Income Margin		 -37.97% -42.49% -34.80% -16.76% -58.82% -21.11% -6.82% 0.00% 3.99% -53.40%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 -3.56 -9.07 -4.45 -1.86 -11.09 -17.18 -8.04 0.00 0.00 -9.09
NOPAT to Interest Expense		 -2.49 -6.35 -3.12 -1.30 -7.76 -12.09 -5.63 0.00 0.00 -5.73
EBIT Less CapEx to Interest Expense		 -3.75 -10.50 -6.08 -4.56 -11.71 -18.80 -14.41 0.00 0.00 -9.79
NOPAT Less CapEx to Interest Expense		 -2.68 -7.78 -4.74 -4.00 -8.39 -13.71 -12.00 0.00 0.00 -6.43
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Glaukos

This table displays calculated financial ratios and metrics derived from Glaukos' official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 24.58% 28.09% 23.86% 19.02% 15.86% 15.64% 9.51% 10.61% 9.19% -2.75% -4.61%
EBITDA Growth		 63.76% 59.19% 34.49% -4.92% -30.94% -41.83% -63.61% 36.70% -233.39% -151.41% -170.38%
EBIT Growth		 50.78% 25.78% 25.07% -2.60% -21.52% -14.49% -37.52% 27.55% -473.56% -88.79% -326.20%
NOPAT Growth		 47.07% 25.78% 11.96% -3.09% -18.41% -14.49% -29.61% 20.91% -350.16% -88.79% -241.67%
Net Income Growth		 55.57% 8.70% 29.68% -54.04% -17.94% -16.91% -10.40% 27.94% -743.97% -43.84% -542.63%
EPS Growth		 60.98% 25.33% 38.10% -47.06% -13.89% -13.64% -8.62% 29.17% -754.55% -43.48% -546.15%
Operating Cash Flow Growth		 45.32% 104.75% -17.36% -125.08% -10.10% -157.86% 69.19% 33.14% -414.75% 11.07% -249.04%
Free Cash Flow Firm Growth		 -16.44% -7.73% 7.88% 60.74% 51.79% 40.84% -8.62% -17.62% -536.97% -137.34% -216.64%
Invested Capital Growth		 1.19% 0.01% 1.03% -1.25% -2.21% -1.86% 0.94% 4.15% 2.72% 1.79% 1.54%
Revenue Q/Q Growth		 1.10% 9.13% 1.02% 11.76% 3.95% 5.53% -2.92% 8.80% 3.75% -0.06% -1.95%
EBITDA Q/Q Growth		 6.72% 12.38% 39.82% 26.32% -9.03% -40.64% 3.63% 8.05% -17.82% -62.24% 62.71%
EBIT Q/Q Growth		 31.16% -28.73% 29.70% 21.00% -3.81% -29.96% 3.73% 6.43% 2.20% -56.10% 49.28%
NOPAT Q/Q Growth		 27.87% -16.24% 17.73% 23.27% -1.15% -37.89% 3.66% 11.88% 2.20% -56.10% 41.21%
Net Income Q/Q Growth		 45.96% -56.85% 57.64% -23.77% -11.04% -20.81% 7.22% 5.24% -10.06% -14.08% 39.44%
EPS Q/Q Growth		 42.86% -43.59% 61.00% -21.95% -9.33% -19.05% 7.35% 5.56% -9.09% -13.79% 39.58%
Operating Cash Flow Q/Q Growth		 -3,753.06% 105.29% 47.81% 45.77% -217.58% -30.57% -0.09% 73.47% -643.81% 84.40% -117.23%
Free Cash Flow Firm Q/Q Growth		 1.11% 8.43% -44.39% 10.94% 8.51% 21.70% 38.46% -9.37% -12.25% -43.77% 33.36%
Invested Capital Q/Q Growth		 3.89% -3.23% 0.57% 0.07% 2.68% -2.23% -1.70% -0.90% 3.05% 0.55% 1.42%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 77.20% 72.86% 76.64% 76.43% 76.34% 77.06% 76.28% 75.00% 75.55% 75.82% 76.34%
EBITDA Margin		 -10.85% -11.76% -14.65% -24.60% -37.31% -36.92% -27.70% -27.91% -33.02% -30.10% -18.54%
Operating Margin		 -19.39% -27.17% -25.51% -31.32% -45.63% -46.89% -35.89% -36.16% -44.65% -47.36% -30.32%
EBIT Margin		 -18.50% -27.17% -23.04% -33.10% -46.83% -46.89% -38.08% -38.40% -44.65% -47.36% -30.32%
Profit (Net Income) Margin		 -17.01% -31.83% -22.15% -52.82% -47.70% -44.65% -39.01% -40.81% -46.86% -44.17% -38.69%
Tax Burden Percent		 101.83% 99.66% 100.83% 100.66% 100.93% 100.17% 100.12% 101.34% 101.17% 100.96% 100.90%
Interest Burden Percent		 90.31% 117.54% 95.34% 158.53% 100.92% 95.07% 102.32% 104.88% 103.73% 92.38% 126.46%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -11.99% -16.45% -14.12% -16.35% -22.65% -23.09% -16.90% -16.62% -19.67% -20.95% -13.57%
ROIC Less NNEP Spread (ROIC-NNEP)		 -9.53% -8.56% -10.59% 8.57% 47.07% -2.97% 0.62% 0.31% -7.38% -13.87% -3.92%
Return on Net Nonoperating Assets (RNNOA)		 2.35% 2.38% 2.17% -1.76% -1.90% 0.29% -0.08% -0.04% 1.25% 2.75% 0.88%
Return on Equity (ROE)		 -9.64% -14.07% -11.95% -18.11% -24.55% -22.80% -16.98% -16.66% -18.42% -18.19% -12.69%
Cash Return on Invested Capital (CROIC)		 -17.08% -19.33% -21.35% -19.46% -18.26% -18.26% -20.14% -22.24% -21.75% -14.64% -11.96%
Operating Return on Assets (OROA)		 -7.88% -10.88% -8.85% -12.06% -16.04% -15.19% -11.81% -11.47% -12.75% -13.06% -8.34%
Return on Assets (ROA)		 -7.25% -12.75% -8.51% -19.24% -16.34% -14.47% -12.10% -12.19% -13.38% -12.18% -10.64%
Return on Common Equity (ROCE)		 -9.64% -14.07% -11.95% -18.11% -24.55% -22.80% -16.98% -16.66% -18.42% -18.19% -12.69%
Return on Equity Simple (ROE_SIMPLE)		 -16.19% 0.00% -22.37% -23.84% -31.25% 0.00% -27.08% -25.87% -27.37% 0.00% -16.34%
Net Operating Profit after Tax (NOPAT)		 -14 -20 -17 -21 -27 -27 -20 -20 -23 -24 -15
NOPAT Margin		 -13.57% -19.02% -17.86% -21.93% -31.94% -32.82% -25.12% -25.31% -31.25% -33.15% -21.23%
Net Nonoperating Expense Percent (NNEP)		 -2.46% -7.90% -3.53% -24.92% -69.72% -20.11% -17.52% -16.93% -12.30% -7.07% -9.65%
Return On Investment Capital (ROIC_SIMPLE)		 -1.89% -2.62% - - - -3.63% - - - -2.91% -
Cost of Revenue to Revenue		 22.80% 27.14% 23.36% 23.57% 23.66% 22.94% 23.72% 25.00% 24.45% 24.18% 23.66%
SG&A Expenses to Revenue		 66.26% 65.41% 66.20% 69.17% 72.38% 76.53% 69.50% 66.09% 72.60% 72.90% 66.16%
R&D to Revenue		 30.33% 34.62% 35.94% 38.59% 49.58% 47.43% 42.67% 45.07% 47.59% 50.28% 40.51%
Operating Expenses to Revenue		 96.59% 100.03% 102.15% 107.76% 121.97% 123.96% 112.17% 111.16% 120.19% 123.18% 106.66%
Earnings before Interest and Taxes (EBIT)		 -20 -29 -22 -32 -40 -39 -30 -31 -33 -34 -22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -12 -12 -14 -24 -32 -30 -22 -22 -24 -21 -13
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 7.29 10.78 10.71 8.96 10.21 8.40 7.66 7.02 4.72 3.93 4.62
Price to Tangible Book Value (P/TBV)		 12.65 18.90 21.50 18.44 44.81 34.43 29.92 26.97 17.04 13.36 15.05
Price to Revenue (P/Rev)		 13.76 21.56 19.87 17.44 14.10 12.33 12.06 11.57 8.30 7.37 8.90
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 11.44 17.93 15.18 12.64 10.13 8.72 8.03 7.40 5.08 4.46 5.46
Enterprise Value to Revenue (EV/Rev)		 13.02 20.73 19.30 16.84 14.13 12.29 12.00 11.49 8.17 7.11 8.61
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.08 0.09 0.63 0.61 0.59 0.58 0.55 0.53 0.51
Long-Term Debt to Equity		 0.00 0.00 0.08 0.09 0.63 0.61 0.59 0.58 0.55 0.53 0.51
Financial Leverage		 -0.25 -0.28 -0.20 -0.21 -0.04 -0.10 -0.12 -0.14 -0.17 -0.20 -0.22
Leverage Ratio		 1.56 1.56 1.64 1.63 1.99 1.96 1.91 1.89 1.83 1.84 1.80
Compound Leverage Factor		 1.41 1.83 1.56 2.58 2.01 1.86 1.95 1.98 1.90 1.70 2.28
Debt to Total Capital		 0.00% 0.00% 7.83% 7.85% 38.58% 37.98% 37.16% 36.59% 35.65% 34.68% 33.88%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 7.83% 7.85% 38.58% 37.98% 37.16% 36.59% 35.65% 34.68% 33.88%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 92.17% 92.15% 61.42% 62.02% 62.84% 63.41% 64.35% 65.32% 66.12%
Debt to EBITDA		 0.00 0.00 -0.60 -0.57 -2.90 -2.97 -3.30 -3.57 -3.20 -6.25 -8.76
Net Debt to EBITDA		 0.00 0.00 2.16 2.08 -0.11 0.13 0.22 0.28 0.41 1.58 2.51
Long-Term Debt to EBITDA		 0.00 0.00 -0.60 -0.57 -2.90 -2.97 -3.30 -3.57 -3.20 -6.25 -8.76
Debt to NOPAT		 0.00 0.00 -0.61 -0.60 -3.00 -3.14 -3.26 -3.43 -3.22 -4.88 -6.04
Net Debt to NOPAT		 0.00 0.00 2.22 2.16 -0.11 0.14 0.21 0.26 0.41 1.24 1.73
Long-Term Debt to NOPAT		 0.00 0.00 -0.61 -0.60 -3.00 -3.14 -3.26 -3.43 -3.22 -4.88 -6.04
Altman Z-Score		 16.23 23.56 16.30 13.67 5.38 4.58 4.47 4.25 3.00 2.61 3.38
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 6.49 5.99 5.54 5.48 5.38 5.34 5.95 6.28 6.67 6.13 7.40
Quick Ratio		 5.40 5.05 4.45 4.46 4.42 4.53 5.07 5.37 5.70 5.37 6.54
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -20 -20 -22 -15 -17 -19 -24 -39 -35 -32 -22
Operating Cash Flow to CapEx		 -955.68% 29.26% -661.10% -854.77% -3,498.97% -253.09% -243.10% -141.54% -445.34% -50.65% -439.06%
Free Cash Flow to Firm to Interest Expense		 -17.09 -2.56 -13.20 -0.71 -4.95 -4.68 -7.01 -11.39 -10.39 -3.86 -6.30
Operating Cash Flow to Interest Expense		 -15.93 0.06 -5.76 -0.86 -9.82 -2.68 -2.40 -2.40 -9.03 -0.51 -7.62
Operating Cash Flow Less CapEx to Interest Expense		 -17.59 -0.16 -6.64 -0.96 -10.10 -3.73 -3.39 -4.10 -11.05 -1.50 -9.35
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.43 0.40 0.38 0.36 0.34 0.32 0.31 0.30 0.29 0.28 0.27
Accounts Receivable Turnover		 6.85 7.62 7.53 7.55 7.74 8.29 8.19 7.88 7.96 8.14 8.14
Inventory Turnover		 1.79 1.89 1.69 1.67 1.72 1.89 2.00 2.15 2.15 2.27 2.55
Fixed Asset Turnover		 4.07 3.81 3.57 3.37 3.26 3.19 3.19 3.23 3.34 3.46 3.85
Accounts Payable Turnover		 6.86 7.11 7.83 7.97 6.28 5.43 6.76 4.84 6.99 6.35 6.89
Days Sales Outstanding (DSO)		 53.27 47.87 48.49 48.32 47.18 44.03 44.54 46.29 45.87 44.85 44.85
Days Inventory Outstanding (DIO)		 204.01 193.44 215.83 218.26 212.72 192.77 182.64 169.95 169.92 161.00 143.35
Days Payable Outstanding (DPO)		 53.17 51.37 46.59 45.79 58.16 67.24 54.02 75.41 52.22 57.51 52.99
Cash Conversion Cycle (CCC)		 204.11 189.95 217.73 220.79 201.75 169.56 173.16 140.83 163.57 148.34 135.21
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 461 443 458 455 455 443 453 461 465 452 449
Invested Capital Turnover		 0.88 0.87 0.79 0.75 0.71 0.70 0.67 0.66 0.63 0.63 0.64
Increase / (Decrease) in Invested Capital		 5.40 0.03 4.69 -5.78 -10 -8.38 4.22 18 12 7.92 6.81
Enterprise Value (EV)		 5,269 7,948 6,953 5,756 4,612 3,866 3,642 3,411 2,363 2,012 2,453
Market Capitalization		 5,567 8,267 7,159 5,961 4,601 3,879 3,661 3,433 2,399 2,084 2,534
Book Value per Share		 $13.51 $13.91 $12.17 $13.21 $9.09 $9.46 $9.82 $10.14 $10.62 $11.11 $11.53
Tangible Book Value per Share		 $7.78 $7.93 $6.06 $6.42 $2.07 $2.31 $2.51 $2.64 $2.94 $3.27 $3.54
Total Capital		 764 767 725 722 734 745 760 771 790 811 830
Total Debt		 0.00 0.00 57 57 283 283 282 282 282 281 281
Total Long-Term Debt		 0.00 0.00 57 57 283 283 282 282 282 281 281
Net Debt		 -299 -319 -206 -205 10 -13 -18 -22 -36 -71 -81
Capital Expenditures (CapEx)		 1.94 1.73 1.45 2.15 0.97 4.21 3.36 5.77 6.91 8.17 6.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 77 56 63 52 44 26 32 34 36 19 27
Debt-free Net Working Capital (DFNWC)		 376 375 326 314 316 321 332 337 353 372 388
Net Working Capital (NWC)		 376 375 326 314 316 321 332 337 353 372 388
Net Nonoperating Expense (NNE)		 3.67 14 4.15 30 13 9.74 11 12 12 7.85 12
Net Nonoperating Obligations (NNO)		 -303 -324 -210 -210 4.40 -19 -24 -28 -43 -78 -99
Total Depreciation and Amortization (D&A)		 8.16 16 8.10 8.14 8.15 8.21 8.10 8.44 8.59 12 8.40
Debt-free, Cash-free Net Working Capital to Revenue		 19.11% 14.54% 17.52% 15.23% 13.33% 8.27% 10.38% 11.31% 12.36% 6.65% 9.34%
Debt-free Net Working Capital to Revenue		 92.95% 97.70% 90.36% 91.80% 96.92% 102.14% 109.49% 113.67% 122.28% 131.34% 136.28%
Net Working Capital to Revenue		 92.95% 97.70% 90.36% 91.80% 96.92% 102.14% 109.49% 113.67% 122.28% 131.34% 136.28%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.32) ($0.56) ($0.39) ($1.00) ($0.82) ($0.75) ($0.63) ($0.68) ($0.72) ($0.66) ($0.58)
Adjusted Weighted Average Basic Shares Outstanding		 56.64M 52.76M 55.04M 50.72M 49.58M 48.43M 48.68M 48.28M 47.88M 47.44M 47.61M
Adjusted Diluted Earnings per Share		 ($0.32) ($0.56) ($0.39) ($1.00) ($0.82) ($0.75) ($0.63) ($0.68) ($0.72) ($0.66) ($0.58)
Adjusted Weighted Average Diluted Shares Outstanding		 56.64M 52.76M 55.04M 50.72M 49.58M 48.43M 48.68M 48.28M 47.88M 47.44M 47.61M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 57.14M 56.57M 55.14M 54.95M 50.37M 49.47M 48.80M 48.65M 48.21M 47.88M 47.70M
Normalized Net Operating Profit after Tax (NOPAT)		 -14 -20 -17 -21 -27 -27 -20 -20 -23 -24 -15
Normalized NOPAT Margin		 -13.57% -19.02% -17.86% -21.93% -31.94% -32.82% -25.12% -25.31% -31.25% -33.15% -21.23%
Pre Tax Income Margin		 -16.71% -31.94% -21.96% -52.48% -47.26% -44.58% -38.96% -40.27% -46.31% -43.75% -38.35%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -16.97 -3.65 -13.39 -1.48 -11.62 -9.69 -8.75 -9.08 -9.68 -4.12 -6.21
NOPAT to Interest Expense		 -12.45 -2.55 -10.38 -0.98 -7.93 -6.78 -5.77 -5.99 -6.78 -2.89 -4.35
EBIT Less CapEx to Interest Expense		 -18.63 -3.87 -14.26 -1.58 -11.90 -10.75 -9.73 -10.78 -11.71 -5.12 -7.94
NOPAT Less CapEx to Interest Expense		 -14.11 -2.77 -11.25 -1.08 -8.21 -7.84 -6.76 -7.68 -8.80 -3.89 -6.08
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Glaukos' Financials

When does Glaukos's fiscal year end?

According to the most recent income statement we have on file, Glaukos' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Glaukos' net income changed over the last 9 years?

Glaukos' net income appears to be on an upward trend, with a most recent value of -$146.37 million in 2024, rising from -$38.32 million in 2015. The previous period was -$134.66 million in 2023. See Glaukos' forecast for analyst expectations on what’s next for the company.

What is Glaukos's operating income?
Glaukos's total operating income in 2024 was -$122.37 million, based on the following breakdown:
  • Total Gross Profit: $289.45 million
  • Total Operating Expenses: $411.82 million
How has Glaukos revenue changed over the last 9 years?

Over the last 9 years, Glaukos' total revenue changed from $71.70 million in 2015 to $383.48 million in 2024, a change of 434.8%.

How much debt does Glaukos have?

Glaukos' total liabilities were at $207.83 million at the end of 2024, a 56.6% decrease from 2023, and a 868.0% increase since 2015.

How much cash does Glaukos have?

In the past 9 years, Glaukos' cash and equivalents has ranged from $6.49 million in 2016 to $169.63 million in 2024, and is currently $169.63 million as of their latest financial filing in 2024.

How has Glaukos' book value per share changed over the last 9 years?

Over the last 9 years, Glaukos' book value per share changed from 2.97 in 2015 to 13.91 in 2024, a change of 369.1%.


Related Companies

This page (NYSE:GKOS) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...
Augusta Precious Metals | Sponsored